Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype

20 Apr 2002

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmacogenetics and Drug Metabolism
Share to Schizophrenia research and treatment
Share to Treatment of Major Depression

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 12107620
DOI: 10.1007/s00213-002-1059-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotypePMID 12107620Read ↗

The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.Semantic proximity Read ↗

Tamsulosin exposure is significantly increased by the CYP2D6*10/*10 genotype.Semantic proximity Read ↗

Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.Semantic proximity Read ↗

Pharmacogenetics of classical and new antipsychotic drugs.Semantic proximity Read ↗

Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups.Semantic proximity Read ↗

Acute pharmacogenetic dystonic reactions in a family with the CYP2D6 *41 allele: a case report.Semantic proximity Read ↗

A physiologically based pharmacokinetic model for CYP2E1 phenotyping via chlorzoxazoneSemantic proximity Read ↗

Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.Semantic proximity Read ↗

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.Semantic proximity Read ↗

Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.Semantic proximity Read ↗

The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol.Semantic proximity Read ↗

Pharmacokinetics of voriconazole and cytochrome p450 2C19 genetic statusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.